- Home
- BOW vs ORKA Comparison
BOW vs ORKA Comparison
Compare BOW & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOW
- ORKA
- Stock Information
- Founded
- BOW 2020
- ORKA 2004
- Country
- BOW United States
- ORKA United States
- Employees
- BOW N/A
- ORKA N/A
- Industry
- BOW Property-Casualty Insurers
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BOW Finance
- ORKA Health Care
- Exchange
- BOW Nasdaq
- ORKA Nasdaq
- Market Cap
- BOW 1.1B
- ORKA 1.0B
- IPO Year
- BOW 2024
- ORKA N/A
- Fundamental
- Price
- BOW $30.99
- ORKA $11.02
- Analyst Decision
- BOW Hold
- ORKA Strong Buy
- Analyst Count
- BOW 5
- ORKA 7
- Target Price
- BOW $33.60
- ORKA $39.67
- AVG Volume (30 Days)
- BOW 87.7K
- ORKA 263.4K
- Earning Date
- BOW 02-25-2025
- ORKA 03-04-2025
- Dividend Yield
- BOW N/A
- ORKA N/A
- EPS Growth
- BOW 130.44
- ORKA N/A
- EPS
- BOW 1.08
- ORKA N/A
- Revenue
- BOW $389,135,000.00
- ORKA N/A
- Revenue This Year
- BOW N/A
- ORKA N/A
- Revenue Next Year
- BOW $26.69
- ORKA N/A
- P/E Ratio
- BOW $28.69
- ORKA N/A
- Revenue Growth
- BOW 107.43
- ORKA N/A
- 52 Week Low
- BOW $22.14
- ORKA $10.61
- 52 Week High
- BOW $37.81
- ORKA $53.88
- Technical
- Relative Strength Index (RSI)
- BOW N/A
- ORKA N/A
- Support Level
- BOW N/A
- ORKA N/A
- Resistance Level
- BOW N/A
- ORKA N/A
- Average True Range (ATR)
- BOW 0.00
- ORKA 0.00
- MACD
- BOW 0.00
- ORKA 0.00
- Stochastic Oscillator
- BOW 0.00
- ORKA 0.00
About BOW Bowhead Specialty Holdings Inc. Common Stock
Bowhead Specialty Holdings Inc is engaged in providing specialty P&C products. It is a specialty insurance group that generates revenues by underwriting and offering a variety of specialty insurance products to domestic markets through three distinct underwriting divisions: Casualty, Professional Liability and Healthcare. Casualty specialize in GL coverage for risks in the construction, distribution, heavy manufacturing, real estate and hospitality segments and also consider underwriting risks in a broader range of industries. Key revenue is generated from Casualty segment.
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.